Company / Current Liabilities
Krystal Biotech, Inc. Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$102.9M
FY2025
5-year range
$25.7M / $102.9M
FY2021-FY2025
Trend
+0.9%
vs FY2024
Sector context
#93 of 213
Health Care
What the data says
At $103M, Krystal Biotech, Inc.'s current liabilities ranks #121 of 213 in the Health Care sector. Current Liabilities has increased for 9 consecutive years, from $43,000 in FY2016 to $103M in FY2025.
Based on SEC 10-K filings.
$103M in FY2025 with a 5-year CAGR of +46.1%.
Increased from $33M to $103M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +52.8%
- 5-Year CAGR
- +46.1%
- 10-Year CAGR
- -
Sector benchmark
#121 of 213 in Health CareTop 56% of 213This company $102.9M Sector average $1.6B
▼
-93.5% below sector average
Key checks
Key Insights
- Krystal Biotech, Inc.'s current liabilities has grown for 9 consecutive years.
- 5-year CAGR of +46.1%, indicating consistent growth.
- In FY2025, current liabilities increased 0.9% year-over-year.
- Ranks #93 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 5.66 (safe zone, above 2.9 threshold)
- Strong profit margin: 30.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $102.9M | +0.9% |
| FY2024 | $102.0M | +208.2% |
| FY2023 | $33.1M | +14.7% |
| FY2022 | $28.8M | +12.1% |
| FY2021 | $25.7M | +66.6% |
| FY2020 | $15.5M | +364.4% |
| FY2019 | $3.3M | +28.2% |
| FY2018 | $2.6M | +305.6% |
| FY2017 | $640.0K | +1388.4% |
| FY2016 | $43.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026